NBIX
Neurocrine Biosciences, Inc.
Stock
$143.18+2.47 (+1.76%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $3.3B
- YoY, 2025
- +25.6%
- 5-year CAGR
- +23.6%
- 10-year CAGR
- +22.6%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $3.3B | +25.6% |
| 2024 | $2.6B | +16.0% |
| 2023 | $2.2B | +30.7% |
| 2022 | $1.7B | +24.3% |
| 2021 | $1.4B | +22.0% |
| 2020 | $1.1B | +76.8% |
| 2019 | $637M | +32.5% |
| 2018 | $481M | +29.2% |
| 2017 | $372M | +18.2% |
| 2016 | $315M | −25.8% |
| 2015 | $424M | +103.4% |
| 2014 | $209M | +73.3% |
| 2013 | $120M | −22.0% |
| 2012 | $154M | +156.9% |
| 2011 | $60M | +210.6% |
| 2010 | $19M | +389.3% |
| 2009 | $4.0M | — |